1. Home
  2. ARTL vs ELWS Comparison

ARTL vs ELWS Comparison

Compare ARTL & ELWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • ELWS
  • Stock Information
  • Founded
  • ARTL 2011
  • ELWS 2018
  • Country
  • ARTL United States
  • ELWS Japan
  • Employees
  • ARTL N/A
  • ELWS N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • ELWS
  • Sector
  • ARTL Health Care
  • ELWS
  • Exchange
  • ARTL Nasdaq
  • ELWS Nasdaq
  • Market Cap
  • ARTL 4.2M
  • ELWS 6.7M
  • IPO Year
  • ARTL N/A
  • ELWS 2023
  • Fundamental
  • Price
  • ARTL $1.20
  • ELWS $2.34
  • Analyst Decision
  • ARTL Strong Buy
  • ELWS
  • Analyst Count
  • ARTL 1
  • ELWS 0
  • Target Price
  • ARTL $5.00
  • ELWS N/A
  • AVG Volume (30 Days)
  • ARTL 7.3K
  • ELWS 2.2M
  • Earning Date
  • ARTL 08-13-2024
  • ELWS 09-17-2024
  • Dividend Yield
  • ARTL N/A
  • ELWS N/A
  • EPS Growth
  • ARTL N/A
  • ELWS N/A
  • EPS
  • ARTL N/A
  • ELWS N/A
  • Revenue
  • ARTL N/A
  • ELWS $1,139,113.00
  • Revenue This Year
  • ARTL N/A
  • ELWS N/A
  • Revenue Next Year
  • ARTL N/A
  • ELWS N/A
  • P/E Ratio
  • ARTL N/A
  • ELWS N/A
  • Revenue Growth
  • ARTL N/A
  • ELWS 285.14
  • 52 Week Low
  • ARTL $1.15
  • ELWS $1.04
  • 52 Week High
  • ARTL $1.94
  • ELWS $13.00
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 39.90
  • ELWS 46.68
  • Support Level
  • ARTL $1.20
  • ELWS $2.43
  • Resistance Level
  • ARTL $1.27
  • ELWS $3.00
  • Average True Range (ATR)
  • ARTL 0.06
  • ELWS 0.38
  • MACD
  • ARTL -0.01
  • ELWS -0.08
  • Stochastic Oscillator
  • ARTL 0.07
  • ELWS 12.41

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

About ELWS Earlyworks Co. Ltd.

Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.

Share on Social Networks: